Pharmacists in Enfield, Connecticut


45 Pharmacists found in Enfield
male pharmacist

Paul Ernest Dufresne, MS, R.PH., DPH


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
31 Moody Rd, Enfield, CT 06082
860-763-7020     860-763-7022

female pharmacist

Pearl-ruth Eben


Pharmacist
54 Hazard Ave, Enfield, CT 06082
860-741-2230    

male pharmacist

Peter Charles Kuselias, PHARMD


Pharmacist
2 Shaker Rd, Enfield, CT 06082
860-253-0463    



male pharmacist

Phillip Boglisch, PHARMD


Pharmacist
75 Freshwater Blvd, Enfield, CT 06082
860-394-2028     860-394-2025

female pharmacist

Radha Bhargava


Pharmacist
90 Elm St, T1255, Enfield, CT 06082
860-741-8054    

male pharmacist

Mr. Richard Edward Fournier Sr., BS:PHARMACY


Pharmacist
585 Hazard Ave, Enfield, CT 06082
860-749-8113    

male pharmacist

Dr. Robert Angelo Trimani, PHARMD


Pharmacist
75 Freshwater Blvd, Enfield, CT 06082
860-394-2028     860-394-2025

female pharmacist

Sally Hartman


Pharmacist
875 Enfield St, Enfield, CT 06082
860-741-3014     860-741-5434

female pharmacist

Sara E Kaprove, PHARMD


Pharmacist
71 Palomba Dr, Enfield, CT 06082
860-749-4184    

female pharmacist

Sarah Alicea, PHARMD


Pharmacist
30 Hazard Ave, Enfield, CT 06082
860-741-3503    

female pharmacist

Sharmin Arshad Contractor, PHARMACIST


Pharmacist
90 Elm St, Enfield, CT 06082
860-741-8054    

male pharmacist

Mr. Thomas Anthony Szewczyk, RPH


Pharmacist
89 Raffia Rd, Enfield, CT 06082
860-749-8334     860-749-8156

male pharmacist

Thomas Francis Padrevita, PHARMD


Pharmacist
71 Palomba Dr, Enfield, CT 06082
860-749-4184    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.